Evidence map›Paper›PMID 19922964›Full record

ArticleMetabolism: clinical and experimental2010

Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

Margo P Cohen, Elizabeth A Shea, Van-Yu Wu

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Margo P CohenGlycadia, Inc, Philadelphia, PA 19103, USA. drmpcohen@aol.com
Elizabeth A Shea
Van-Yu Wu
Cascadia Research Collective · US

Funding

LDL Modification in Diabetic ComplicationsR44DK072587 · NIDDK · EXOCELL, INC. · PI COHEN, MARGO · 2006 to 2007
$1.8M
NIDDK NIH HHS R44 DK072587PHS HHS 72587
6 · The paper itself

Abstract

Increased nonenzymatic glycation of apolipoprotein (apo) B-containing lipoproteins impairs uptake and metabolism by the high-affinity low-density lipoprotein receptor and is one of the postsecretory modifications contributory to accelerated atherosclerosis in diabetes. The present study evaluated in vitro and in vivo effects of 2,2-chlorophenylaminophenylacetate to probe the influence of glycated lipoprotein on cholesterol homeostasis. This compound prevented the increased formation of glycated products in low-density lipoprotein incubated with 200 mmol/L glucose and the increased cholesteryl ester synthesis in THP-1 macrophages induced by apo B-containing lipoproteins preincubated with high glucose concentration. The elevated circulating concentrations of glycated lipoprotein and cholesterol and higher vascular levels of lipid peroxidation products observed in streptozotocin diabetic rats compared with nondiabetic controls were significantly reduced in diabetic animals treated for 6 months with test compound. These results are the first to demonstrate that inhibiting nonenzymatic glycation of apo B-containing lipoproteins ameliorates abnormalities contributory to hypercholesterolemia and atherogenic risk in diabetes.

Indexed as

AnimalsApolipoproteins BAtherosclerosisCholesterol EstersDiabetes Mellitus, ExperimentalDiclofenacGlycosylationHypercholesterolemiaLipid PeroxidationLipoproteins, LDLMacrophagesMaleRatsRats, WistarThiobarbituric Acid Reactive Substances2-(3-chlorophenylamino)phenylacetic acidApolipoproteins BCholesterol EstersDiclofenacLipoproteins, LDLlow density lipoprotein inhibitorThiobarbituric Acid Reactive Substances

Identifiers

PMID19922964
PMCPMC2856719
OpenAlexW2067424744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.